152 related articles for article (PubMed ID: 16015686)
1. Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes.
He XH; Xu LH; Liu Y
World J Gastroenterol; 2005 Jul; 11(27):4180-7. PubMed ID: 16015686
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and characterization of HLA-A * 0201 monomer and tetramer loaded with HCMV antigenic peptide].
He XH; Xu LH; Liu Y; Cai XC; Zeng YY
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):382-8. PubMed ID: 15971610
[TBL] [Abstract][Full Text] [Related]
3. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].
Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781
[TBL] [Abstract][Full Text] [Related]
4. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
[TBL] [Abstract][Full Text] [Related]
5. Preparation and identification of HLA-A*1101 tetramer loading with human cytomegalovirus pp65 antigen peptide.
Li F; Xu L; Zha Q; Chi X; Jia Q; He X
Cell Mol Immunol; 2007 Apr; 4(2):141-6. PubMed ID: 17484809
[TBL] [Abstract][Full Text] [Related]
6. [Expression and refolding of a HLA-A*0203-BSP fusion protein and identification of its tetramers].
Jia QT; Xu LH; Zha QB; Li FY; He XH; Zeng YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):97-101. PubMed ID: 17286897
[TBL] [Abstract][Full Text] [Related]
7. [Construction and characterization of soluble HLA-A*0201-PR1 complex].
Sun WJ; Xu DG; Hu HL; Zou MJ; DU JF; Wang JF; Cai X; Wang JX; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):352-6. PubMed ID: 17493346
[TBL] [Abstract][Full Text] [Related]
8. High level expression of HLA-A*0203-BSP fusion protein in Escherichia coli and construction of soluble HLA-A*0203 monomer and tetramer loaded with Epstein-Barr virus peptide.
Jia Q; Xu L; Zha Q; Chi X; Li F; He X
Cell Mol Immunol; 2007 Aug; 4(4):301-8. PubMed ID: 17764621
[TBL] [Abstract][Full Text] [Related]
9. [In-vitro refolding and biotinylation of soluble HLA-A2-peptide complex].
Wong XF; Chen H; Wu XW; Liang ZH; Han JY; Huan YF; Gong FL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):265-8. PubMed ID: 15193213
[TBL] [Abstract][Full Text] [Related]
10. [Improved expression of HLA-A* 2402-BSP in Escherichia coli and its tetramer preparation].
Jia QT; Xu LH; Li FY; Zha QB; He XH
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):284-91. PubMed ID: 17460903
[TBL] [Abstract][Full Text] [Related]
11. [Construction of three HLA-A*0201-peptide tetramers and their preliminary application in detection of vitiligo-specific cytotoxic T lymphocytes].
Wu JQ; Shi J; Dong JF; Jiang YX; Zhuang SH; Yang J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 43(5):553-8. PubMed ID: 25372640
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coli.
Piao WH; Song XG; Liu MC; He Y; Zhang HH; Xu WX; Li ZL; Zhang HQ; Ling SG; Wang GQ
Protein Expr Purif; 2004 Jun; 35(2):210-7. PubMed ID: 15135395
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and expression of HLA-A*0201-BSP].
Sun WJ; DU JF; Xu DG; Zou MJ; Wang JF; Cai X; Wang Y; Wang JX; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):976-80. PubMed ID: 17096901
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
Yang X; Chen G; Weng NP; Mariuzza RA
J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
[TBL] [Abstract][Full Text] [Related]
15. Construction and functional test of a chicken MHC-I (BF2*15)/peptide tetramer.
Liu G; Wang Q; Tong T; Xiao Y; Bai Y; Liu S; Wu D
Vet Immunol Immunopathol; 2008 Mar; 122(1-2):1-7. PubMed ID: 18077001
[TBL] [Abstract][Full Text] [Related]
16. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro.
Silver ML; Parker KC; Wiley DC
Nature; 1991 Apr; 350(6319):619-22. PubMed ID: 2017257
[TBL] [Abstract][Full Text] [Related]
18. In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.
Yang J; Jaramillo A; Shi R; Kwok WW; Mohanakumar T
Hum Immunol; 2004 Jul; 65(7):692-9. PubMed ID: 15301857
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants.
Engstrand M; Tournay C; Peyrat MA; Eriksson BM; Wadström J; Wirgart BZ; Romagné F; Bonneville M; Tötterman TH; Korsgren O
Transplantation; 2000 Jun; 69(11):2243-50. PubMed ID: 10868621
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes.
Oved K; Lev A; Noy R; Segal D; Reiter Y
Cancer Immunol Immunother; 2005 Sep; 54(9):867-79. PubMed ID: 15906027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]